211 related articles for article (PubMed ID: 20391479)
1. Prospective validation of the provisional criteria for the evaluation of response to therapy in childhood-onset systemic lupus erythematosus.
Brunner HI; Higgins GC; Wiers K; Lapidus SK; Olson JC; Onel K; Punaro M; Ying J; Klein-Gitelman MS; Giannini EH
Arthritis Care Res (Hoboken); 2010 Mar; 62(3):335-44. PubMed ID: 20391479
[TBL] [Abstract][Full Text] [Related]
2. Minimal clinically important differences of disease activity indices in childhood-onset systemic lupus erythematosus.
Brunner HI; Higgins GC; Klein-Gitelman MS; Lapidus SK; Olson JC; Onel K; Punaro M; Ying J; Giannini EH
Arthritis Care Res (Hoboken); 2010 Jul; 62(7):950-9. PubMed ID: 20589695
[TBL] [Abstract][Full Text] [Related]
3. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
[TBL] [Abstract][Full Text] [Related]
4. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
Castrejón I; Tani C; Jolly M; Huang A; Mosca M
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
[TBL] [Abstract][Full Text] [Related]
5. The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement.
Ruperto N; Ravelli A; Oliveira S; Alessio M; Mihaylova D; Pasic S; Cortis E; Apaz M; Burgos-Vargas R; Kanakoudi-Tsakalidou F; Norambuena X; Corona F; Gerloni V; Hagelberg S; Aggarwal A; Dolezalova P; Saad CM; Bae SC; Vesely R; Avcin T; Foster H; Duarte C; Herlin T; Horneff G; Lepore L; van Rossum M; Trail L; Pistorio A; Andersson-Gäre B; Giannini EH; Martini A;
Arthritis Rheum; 2006 Jun; 55(3):355-63. PubMed ID: 16739203
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
Ward MM; Marx AS; Barry NN
J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
[TBL] [Abstract][Full Text] [Related]
7. American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus.
Brunner HI; Holland MJ; Beresford MW; Ardoin SP; Appenzeller S; Silva CA; Flores F; Goilav B; Avar Aydin PO; Wenderfer SE; Levy DM; Ravelli A; Khubchandani R; Avcin T; Klein-Gitelman MS; Ruperto N; Feldman BM; Ying J;
Arthritis Care Res (Hoboken); 2019 May; 71(5):579-590. PubMed ID: 30680946
[TBL] [Abstract][Full Text] [Related]
8. European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus.
Brunner HI; Silverman ED; Bombardier C; Feldman BM
Arthritis Rheum; 2003 Jun; 49(3):335-41. PubMed ID: 12794788
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity analyses of four systemic lupus erythematosus disease activity indices in predicting the treatment changes in consecutive visits: a longitudinal study.
Fatemi A; Raeisi A; Sayedbonakdar Z; Smiley A
Clin Rheumatol; 2018 Apr; 37(4):955-962. PubMed ID: 29256112
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
Sato JO; Corrente JE; Saad-Magalhães C
Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556
[TBL] [Abstract][Full Text] [Related]
11. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
[TBL] [Abstract][Full Text] [Related]
12. Preliminary criteria for global flares in childhood-onset systemic lupus erythematosus.
Brunner HI; Mina R; Pilkington C; Beresford MW; Reiff A; Levy DM; Tucker LB; Eberhard BA; Ravelli A; Schanberg LE; Saad-Magalhaes C; Higgins GC; Onel K; Singer NG; von Scheven E; Itert L; Klein-Gitelman MS; Punaro M; Ying J; Giannini EH
Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1213-23. PubMed ID: 21618452
[TBL] [Abstract][Full Text] [Related]
13. Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus.
Mina R; Klein-Gitelman MS; Nelson S; Eberhard BA; Higgins G; Singer NG; Onel K; Tucker L; O'Neil KM; Punaro M; Levy DM; Haines K; Martini A; Ruperto N; Lovell D; Brunner HI
Ann Rheum Dis; 2014 Feb; 73(2):401-6. PubMed ID: 23345596
[TBL] [Abstract][Full Text] [Related]
14. American College of Rheumatology Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus.
Brunner HI; Holland M; Beresford MW; Ardoin SP; Appenzeller S; Silva CA; Flores F; Goilav B; Wenderfer SE; Levy DM; Ravelli A; Khunchandani R; Avcin T; Klein-Gitelman MS; Feldman BM; Ruperto N; Ying J;
Arthritis Care Res (Hoboken); 2018 Jun; 70(6):813-822. PubMed ID: 29693328
[TBL] [Abstract][Full Text] [Related]
15. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study.
Ramirez GA; Canti V; Moiola L; Magnoni M; Rovere-Querini P; Coletto LA; Dagna L; Manfredi AA; Bozzolo EP
Int J Rheum Dis; 2019 Sep; 22(9):1752-1761. PubMed ID: 31379114
[TBL] [Abstract][Full Text] [Related]
16. Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage.
Brunner HI; Jones OY; Lovell DJ; Johnson AM; Alexander P; Klein-Gitelman MS
Lupus; 2003; 12(8):600-6. PubMed ID: 12945718
[TBL] [Abstract][Full Text] [Related]
17. Toward the development of criteria for global flares in juvenile systemic lupus erythematosus.
Brunner HI; Klein-Gitelman MS; Higgins GC; Lapidus SK; Levy DM; Eberhard A; Singer N; Olson JC; Onel K; Punaro M; Schanberg L; von Scheven E; Ying J; Giannini EH
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):811-20. PubMed ID: 20535792
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity.
Hinze CH; Suzuki M; Klein-Gitelman M; Passo MH; Olson J; Singer NG; Haines KA; Onel K; O'Neil K; Silverman ED; Tucker L; Ying J; Devarajan P; Brunner HI
Arthritis Rheum; 2009 Sep; 60(9):2772-81. PubMed ID: 19714584
[TBL] [Abstract][Full Text] [Related]
19. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms.
Askanase AD; Castrejón I; Pincus T
J Rheumatol; 2011 Jul; 38(7):1309-16. PubMed ID: 21459938
[TBL] [Abstract][Full Text] [Related]
20. The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set.
Ruperto N; Ravelli A; Cuttica R; Espada G; Ozen S; Porras O; Sztajnbok F; Falcini F; Kasapcopur O; Venning H; Bica B; Merino R; Coto C; Ros J; Susic G; Gamir ML; Minden K; See Y; Uziel Y; Mukamel M; Riley P; Zulian F; Olivieri AN; Cimaz R; Girschick H; Rumba I; Cavuto S; Pistorio A; Lovell DJ; Martini A; ;
Arthritis Rheum; 2005 Sep; 52(9):2854-64. PubMed ID: 16142708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
